Table 1.
S. No. | Structure | Additional Functions | References |
---|---|---|---|
1 | Antioxidant activity, protective properties against the injury caused by H2O2 | [81] | |
2 | 2a-d: excellent metal chelating properties. 2a,b: inhibitory potency against AChE-induced Aβ aggregation | [82] | |
3 | Promising in vivo AChE inhibition profile |
[83] | |
4 | Inhibitory potency against PAS and AChE-induced Aβ aggregation, ability to induce S-phase post-treatment | [84] | |
5 | Inhibitory potency against Aβ self-aggregation at the level of 47% at 20 µM, antioxidant properties towards PC12 cells from CoCl2-damage | [85] | |
6 | Neuroprotective activity towards SH-SY5Y cells against rotenone plus oligomycin-A or okadaic acid | [86] | |
7 | 7b,c,f: neuroprotective activity on SH-SY5Y cell line | [88] | |
8 | Antioxidant properties, inhibition of Aβ1-42 aggregation, neuroprotection of SH-SY5Y in the presence of H2O2 | [89] | |
9 | Inhibition of self-/Cu-induced Aβ aggregation, radical scavenging capacity and metal chelating properties (Fe, Cu, Zn), neuroprotection in SH-SY5Y cells treated with Aβ1-42 ascorbate/iron stressors | [96] | |
10 | Inhibition of Aβ self-aggregation amelioration, the impairment of memory in mice models treated with scopolamine in the Morris water maze test | [97] | |
11 | Inhibition of Aβ aggregation | [100] | |
12 | Antioxidant activity and neuroprotection against Aβ1-40 in SH-SY5Y cells | [101] | |
13 | Improvement of cognitive and locomotor activity in a mouse model with AD in the step-through test and open field test, an increase of the amount of H2S in hippocampus, decrease mRNA expression of the proinflammatory cytokines, TNF-α, IL-6, and IL-1β and increase synapse-associated in the hippocampus of tested mice | [108] | |
14 | Inhibition of Aβ42 self-aggregation, neuroprotection in rats neurons in a serum and K+ deprivation model | [111] | |
15 | Ability to cross the BBB in vitro | [120] | |
16 | Inhibition of hMAO A, and MAO-B, strong antioxidant properties |
[127] | |
17 | Strong antioxidant effect with the oxygen radical absorbance capacity | [129] | |
18 | Inhibition of MAO-B and Aβ1−42 aggregation, antioxidant effect, ability to chelat Cu2+ ions, to protect PC12 cells from oxidative stress caused by H2O2, rotenone, and oligomycin-A, to protect BV-2 cells from LPS-Stimulated Inflammation, improvement of cognition and spatial memory against scopolamine-induced acute memory deficit, D-galactose (D-gal) and AlCl3 induced chronic oxidative stress in mice model without acute toxicity and hepatotoxicity, ability to cross the BBB in vitro |
[130] | |
19 | Inhibitory activity against hMAO-B, self-induced and hAChE-induced Aβ aggregation, antioxidant properties, the neuroprotective effects on PC12 cells treated with H2O2 and against LPS-stimulated inflammation on BV-2 cells, ability to cross the BBB in vitro, good liver metabolic stability in RLM, dose-dependently reversed scopolamine-induced memory deficit in mice model but without acute toxicity | [131] | |
20 | Anti-inflammatory properties in vivo in mice model, antioxidant activity in SH-SY5Y cell line and ability to chelate Cu2+ and Fe2+ ions, protection of SH-SY5Y cells against the late neuronal death caused by Aβ1-42 oligomers | [132] | |
21 | ADME profile in silico, anti-inflammatory and neuroprotective activity against AβO-induced neuroinflammation and neurodegeneration in vitro in THP-1 cells and in vivo in mice model | [135] | |
22 | Inhibitory activity against BACE1 and Aβ1−42 aggregation, neuroprotective properties against Aβ1−42-induced damage in SH-SY5Y cells |
[139] | |
23 | Inhibitory activity against Aβ self-aggregation and Cu2+-induced Aβ aggregation, ability to protect SH-SY5Y cells from the Aβ-induced toxicity | [141] | |
24 | Inhibitory potency against MAO-B, ability to cross the BBB in vitro | [143] | |
25 | Selective Cu2+ chelator in a 1:1 ratio, ability to cross the BBB in vitro, activity against MAO-B | [144] | |
26 | Inhibition of PDE9A | [153] | |
27 | Ability to inhibit self-induced and Cu2+-induced Aβ1-42 aggregation, inhibitory activity against MAO-B, antioxidative properties, ability to chelate metals and to cross the BBB in vitro | [154] | |
28 | Prevention from ROS in SH-SY5Y cell line | [155] | |
29 | Anti-inflammatory and antioxidant activity in BV-2 cells, the induction of proteins expression (i.e. GSH) involved in the antioxidant defense in SH-SY5Y cell line, a decrease of ROS levels and NO-release in BV-2 cells | [156] | |
30 | Antioxidative activity, selective metal chelator and neuroprotector against H2O2-induced PC12 cell injury, ability to pass the BBB in vitro, relevant neuroprotective effects in scopolamine-induced cognitive impairment in mice model | [157] | |
31 |
31a-c: pleiotropic activities 31d-f: protection from the self-mediated Aβ aggregation, 31e,f: neuroprotective effect in HT22 cells against glutamate-índuced neuronal death |
[158] | |
32 | Prevention of Aβ self-aggregation in TEM observation, ABTS+ scavenging, and ability to chelat Cu2+ ions | [159] | |
33 | Prevention of Aβ self-aggregation, protection of HT22 cells from glutamate and H2O2 induced cell death, scavenging free radicals and Cu2 ions chelation | [160] | |
34 | Antioxidant activity, neuroprotection of H2O2- induced PC12 cells and Aβ1-42- induced SH-SY5Y cells, hepatoprotection of H2O2- induced LO2 cells, selective metal chelator, activity against Cu2+/hAChE/self-induced Aβ1-42 aggregation, disaggregation of Cu2+-induced Aβ1-42 aggregation, ability to pass the BBB in vitro | [161] |